News
In an era where cyber threats are escalating in complexity and frequency, the integration of machine learning (ML) into cybersecurity has become imperative. Recent reports indicate that adversaries ...
Fellou, the Silicon Valley pioneer behind the world’s first Agentic AI Browser, officially announces the upcoming launch of the world’s first Agentic AI Browser, a revolutionary browser designed to ...
20h
Daily Voice on MSNJonathon Wagner Let Go From Johns Hopkins After ArrestNew details have emerged in an apparent Anti-Semitic incident involving a Jewish-owned business. Jonathon Wagner, who was ...
NYC Republican mayoral candidate Curtis Sliwa’s crime prevention group, The Guardian Angels, is soliciting donations while ...
1d
PRIMETIMER on MSNWho was Kevin Mares? GoFundMe raises over $25,000 for family of US tourist killed in Bad Bunny La Perla Puerto Rico concertKevin Mares, a 25-year-old US tourist, was in Puerto Rico to attend a Bad Bunny concert when he was fatally shot. According to NBC 6 South Florida, police said Mares was in La Perla, a seaside shanty ...
Pierson has cozied up to everyone from Diane Von Furstenberg to Selena Gomez, burnishing her image as her businesses ...
As global digital platforms scale to serve billions of users, the need for robust, extensible, and developer-friendly backends has never been more urgent. Designing systems that can not only handle ...
Medtronic — the world's largest medical device company — named Neptune's successor as he shared his plans for what's next.
Exclusive: NAB allowed an executive who was the subject of sexual harassment claims to have a farewell tour, amid an exodus ...
The Today’s Dietitian 13th annual Spring Symposium will be returning to vibrant Orlando, Florida, in 2026. Secure your spot today by registering at www.todaysdietitian.com/ss26. We are excited to see ...
A recent cyberattack exposed the sensitive personal data of thousands of women who used the Tea Dating Advice app to discuss ...
Present results of the TACTIVE-N trial, a Phase 2 clinical trial of neoadjuvant vepdegestrant, in a mini oral session at European Society for Medical Oncology 2025 Congress (ClinicalTrials.gov ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results